Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Drug Costs"" wg kryterium: Temat


Tytuł :
Deregulation and pricing of medical services: a policy experiment based in China.
Autorzy :
Zang W; School of Insurance, Southwestern University of Finance and Economics, Chengdu, China.
Zhou M; School of Public Administration, Southwestern University of Finance and Economics, Chengdu, China.
Zhao S; School of Economics, Sichuan University, Chengdu, China. .
Pokaż więcej
Źródło :
BMC health services research [BMC Health Serv Res] 2021 May 25; Vol. 21 (1), pp. 501. Date of Electronic Publication: 2021 May 25.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Costs*
Health Expenditures*
China ; Costs and Cost Analysis ; Humans ; Policy
Czasopismo naukowe
Tytuł :
How Well Does a Sequential Minimal Optimization Model Perform in Predicting Medicine Prices for Procurement System?
Autorzy :
Pentrakan A; Department of Healthcare Administration, Asia University, Taichung 41354, Taiwan.; Department of Pharmacy Administration, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla 90112, Thailand.
Yang CC; Department of Healthcare Administration, Asia University, Taichung 41354, Taiwan.
Wong WK; Fintech Center, and Big Data Research Center, Department of Finance, Asia University, Taichung 41354, Taiwan.; Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan.; Department of Economics and Finance, The Hang Seng University of Hong Kong, Hong Kong 999077, Hong Kong.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2021 May 21; Vol. 18 (11). Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Costs*
Drugs, Generic*
Health Expenditures ; Thailand
Czasopismo naukowe
Tytuł :
Evaluation of Drug Wastage in the Operating Rooms and Intensive Care Units of a Regional Health Service.
Autorzy :
Barbariol F; From the Department of Anesthesia and Intensive Care Medicine, University-Hospital of Udine, Udine, Italy.
Deana C; From the Department of Anesthesia and Intensive Care Medicine, University-Hospital of Udine, Udine, Italy.
Lucchese F; From the Department of Anesthesia and Intensive Care Medicine, University-Hospital of Udine, Udine, Italy.
Cataldi G; Department of Anesthesia and Intensive Care Medicine, Monsignor Raffaele Dimiccoli Hospital, Barletta, Italy.
Bassi F; From the Department of Anesthesia and Intensive Care Medicine, University-Hospital of Udine, Udine, Italy.
Bove T; Department of Anesthesia and Intensive Care Medicine, University of Udine, University-Hospital of Udine, Udine, Italy.
Vetrugno L; Department of Anesthesia and Intensive Care Medicine, University of Udine, University-Hospital of Udine, Udine, Italy.
De Monte A; From the Department of Anesthesia and Intensive Care Medicine, University-Hospital of Udine, Udine, Italy.
Pokaż więcej
Źródło :
Anesthesia and analgesia [Anesth Analg] 2021 May 01; Vol. 132 (5), pp. 1450-1456.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Drug Costs*
Hospital Costs*
Anesthetics/*administration & dosage
Anesthetics/*economics
Emergency Service, Hospital/*economics
Intensive Care Units/*economics
Medical Waste/*economics
Operating Rooms/*economics
Anesthetics/supply & distribution ; Cost Savings ; Cost-Benefit Analysis ; Drug Compounding/economics ; Drug Utilization/economics ; Humans ; Italy ; Medical Waste/prevention & control ; Prospective Studies ; Syringes/economics ; Time Factors ; Workflow
Czasopismo naukowe
Tytuł :
The rising cost of commonly used emergency department medications (2006-15).
Autorzy :
Tebo C; Georgetown University School of Medicine, Washington, DC, United States of America. Electronic address: .
Mazer-Amirshahi M; Georgetown University School of Medicine, Washington, DC, United States of America; Department of Emergency Medicine, MedStar Washington Hospital Center, Washington, DC, United States of America. Electronic address: .
Zocchi MS; Heller School for Social Policy and Management, Brandeis University, Boston, MA, United States of America.
Gibson C; Georgetown University School of Medicine, Washington, DC, United States of America. Electronic address: .
Rosenwohl-Mack S; University of California, San Francisco, CA, United States of America. Electronic address: .
Hsia RY; University of California, San Francisco, CA, United States of America.
Fox ER; University of Utah, United States of America. Electronic address: .
Nelson LS; Rutgers New Jersey Medical School, Newark, NJ, United States of America.
Pines JM; US Acute Care Solutions, Canton, OH, United States of America.
Pokaż więcej
Źródło :
The American journal of emergency medicine [Am J Emerg Med] 2021 Apr; Vol. 42, pp. 137-142. Date of Electronic Publication: 2020 Feb 13.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Costs*
Emergency Service, Hospital/*economics
Prescription Drugs/*economics
Cross-Sectional Studies ; Epinephrine/economics ; Glucagon/economics ; Humans ; Pantoprazole/economics ; Patient Discharge ; Pravastatin/economics ; United States
Czasopismo naukowe
Tytuł :
The 'Netflix plus model': can subscription financing improve access to medicines in low- and middle-income countries?
Autorzy :
Cherla A; Department of Health Policy, London School of Economics and Political Science, London, UK.; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.
Howard N; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.
Mossialos E; Department of Health Policy, London School of Economics and Political Science, London, UK.
Pokaż więcej
Źródło :
Health economics, policy, and law [Health Econ Policy Law] 2021 Apr; Vol. 16 (2), pp. 113-123. Date of Electronic Publication: 2020 Mar 03.
Typ publikacji :
Journal Article
MeSH Terms :
Contracts*
Drug Costs*
Fees and Charges*
Financing, Organized/*methods
Health Services Accessibility/*economics
Prescription Drugs/*economics
Cost Control/methods ; Developing Countries ; Drugs, Generic/economics ; Economic Competition ; Economics, Pharmaceutical ; Group Purchasing ; Orphan Drug Production/economics
Czasopismo naukowe
Tytuł :
The impact of early phase price agreements on prices of orphan drugs.
Autorzy :
Nuijten M; A2M, Amsterdam, The Netherlands. .
Van Wilder P; Ecole de Santé Publique, Université Libre de Bruxelles, Bruxelles, Belgium.
Pokaż więcej
Źródło :
BMC health services research [BMC Health Serv Res] 2021 Mar 12; Vol. 21 (1), pp. 222. Date of Electronic Publication: 2021 Mar 12.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Costs*
Orphan Drug Production*
Budgets ; Cost-Benefit Analysis ; Humans ; Negotiating
Czasopismo naukowe
Tytuł :
Potential Cost Implications of Mandatory Non-Medical Switching Policies for Biologics for Rheumatic Conditions and Inflammatory Bowel Disease in Canada.
Autorzy :
Crosby M; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Tadrous M; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.; Women's College Hospital, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.
Gomes T; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Mar; Vol. 109 (3), pp. 739-745. Date of Electronic Publication: 2020 Oct 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Costs*
Biological Products/*economics
Biological Products/*therapeutic use
Biosimilar Pharmaceuticals/*economics
Biosimilar Pharmaceuticals/*therapeutic use
Drug Substitution/*economics
Inflammatory Bowel Diseases/*drug therapy
Rheumatic Diseases/*drug therapy
Tumor Necrosis Factor Inhibitors/*economics
Tumor Necrosis Factor Inhibitors/*therapeutic use
Adalimumab/economics ; Adalimumab/therapeutic use ; Biological Products/adverse effects ; Biosimilar Pharmaceuticals/adverse effects ; Canada ; Cost Savings ; Cost-Benefit Analysis ; Cross-Sectional Studies ; Etanercept/economics ; Etanercept/therapeutic use ; Humans ; Inflammatory Bowel Diseases/economics ; Infliximab/economics ; Infliximab/therapeutic use ; Policy Making ; Public Health/economics ; Rheumatic Diseases/economics ; Time Factors ; Tumor Necrosis Factor Inhibitors/adverse effects
Czasopismo naukowe
Tytuł :
The role of fentanyl in the treatment of breakthrough cancer pain: Different biotechnologies, different results and different drug costs.
Autorzy :
Giuliani J; Department of Oncology, Mater Salutis Hospital, Scaligera, Legnago, VR, Italy.
Fiorica F; Department of Radiation Oncology, Mater Salutis Hospital, Scaligera, Legnago, VR, Italy.
Sacchetto A; Palliative Care Unit, Mater Salutis Hospital, Scaligera, Legnago, VR, Italy.
Franceschini G; Palliative Care Unit, Mater Salutis Hospital, Scaligera, Legnago, VR, Italy.
Vaccari F; Palliative Care Unit, Mater Salutis Hospital, Scaligera, Legnago, VR, Italy.
Bonetti A; Department of Oncology, Mater Salutis Hospital, Scaligera, Legnago, VR, Italy.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Mar; Vol. 27 (2), pp. 445-447. Date of Electronic Publication: 2020 Dec 26.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Costs*
Analgesics, Opioid/*economics
Breakthrough Pain/*drug therapy
Cancer Pain/*drug therapy
Fentanyl/*economics
Administration, Buccal ; Administration, Intranasal/economics ; Administration, Oral ; Analgesics, Opioid/administration & dosage ; Cost-Benefit Analysis ; Fentanyl/administration & dosage ; Humans
Czasopismo naukowe
Tytuł :
Estimated Costs and Long-term Outcomes of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health System.
Autorzy :
Williams SB; Division of Urology, Department of Surgery, University of Texas Medical Branch, Galveston.
Howard LE; Durham Veterans Affairs Health Care System, Durham, North Carolina.; Biostatistics Shared Resource, Duke Cancer Institute, Durham, North Carolina.
Foster ML; Durham Veterans Affairs Health Care System, Durham, North Carolina.
Klaassen Z; Section of Urology, Department of Surgery, Augusta University, Medical College of Georgia, Augusta.
Sieluk J; Merck & Co, Inc, Kenilworth, New Jersey.
De Hoedt AM; Durham Veterans Affairs Health Care System, Durham, North Carolina.
Freedland SJ; Durham Veterans Affairs Health Care System, Durham, North Carolina.; Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California.; Center for Integrated Research on Cancer and Lifestyle, Cedars-Sinai Medical Center, Los Angeles, California.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2021 Mar 01; Vol. 4 (3), pp. e213800. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Costs*
BCG Vaccine/*therapeutic use
United States Department of Veterans Affairs/*statistics & numerical data
Urinary Bladder Neoplasms/*drug therapy
Veterans/*statistics & numerical data
Adjuvants, Immunologic/economics ; Adjuvants, Immunologic/therapeutic use ; Aged ; BCG Vaccine/economics ; Disease-Free Survival ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Time Factors ; United States ; Urinary Bladder Neoplasms/diagnosis ; Urinary Bladder Neoplasms/economics
Czasopismo naukowe
Tytuł :
A Cost-Benefit Analysis of VEGF-Inhibitor Therapy for Neovascular Age-Related Macular Degeneration in the United States.
Autorzy :
Brown GC; Center for Value-Based Medicine, Hilton Head, South Carolina, USA; Wills Eye Hospital, Jefferson Medical University, Philadelphia, Pennsylvania, USA; Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: .
Brown MM; Center for Value-Based Medicine, Hilton Head, South Carolina, USA; Wills Eye Hospital, Jefferson Medical University, Philadelphia, Pennsylvania, USA; Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, USA.
Rapuano SB; Center for Value-Based Medicine, Hilton Head, South Carolina, USA; Wills Eye Hospital, Jefferson Medical University, Philadelphia, Pennsylvania, USA.
Boyer D; Retina-Vitreous Associates Medical Group, Los Angeles, California, USA.
Pokaż więcej
Źródło :
American journal of ophthalmology [Am J Ophthalmol] 2021 Mar; Vol. 223, pp. 405-429. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Drug Costs*
Quality-Adjusted Life Years*
Visual Acuity*
Angiogenesis Inhibitors/*economics
Wet Macular Degeneration/*drug therapy
Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/administration & dosage ; Cost-Benefit Analysis ; Female ; Humans ; Incidence ; Intravitreal Injections ; Male ; United States/epidemiology ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Wet Macular Degeneration/economics ; Wet Macular Degeneration/epidemiology
Czasopismo naukowe
Tytuł :
Clinician Perspectives of COVID-19-Related Cancer Drug Funding Measures in Ontario.
Autorzy :
Naipaul RD; Provincial Drug Reimbursement Programs, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Mercer RE; Provincial Drug Reimbursement Programs, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.; Canadian Centre for Applied Research in Cancer Control, Toronto, ON M5G 2L3, Canada.
Chan KKW; Provincial Drug Reimbursement Programs, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.; Canadian Centre for Applied Research in Cancer Control, Toronto, ON M5G 2L3, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
Yeung L; Provincial Drug Reimbursement Programs, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Forbes L; Provincial Drug Reimbursement Programs, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Gavura S; Provincial Drug Reimbursement Programs, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Pokaż więcej
Źródło :
Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Feb 26; Vol. 28 (2), pp. 1056-1066. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Costs*
Antineoplastic Agents/*economics
COVID-19/*epidemiology
Neoplasms/*drug therapy
Antineoplastic Agents/therapeutic use ; Attitude of Health Personnel ; Data Collection ; Health Policy ; Health Services Accessibility ; Humans ; Medical Oncology/economics ; Medical Oncology/organization & administration ; Neoplasms/epidemiology ; Ontario/epidemiology ; Pandemics ; Quality of Health Care ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
International Price Comparisons of Anticancer Drugs: A Scheme for Improving Patient Accessibility.
Autorzy :
Jung JH; College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.; Novartis Korea Ltd., Seoul 07326, Korea.
Kim DJ; College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.
Suh K; Department of Pharmacy & Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA 15217, USA.
You J; College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.
Lee JH; College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.
Joung KI; Graduate School of Public Health, Seoul National University, Seoul 08826, Korea.
Suh DC; College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Jan 14; Vol. 18 (2). Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents*
Drug Costs*
France ; Germany ; Humans ; Italy ; Japan ; Republic of Korea ; Switzerland
Czasopismo naukowe
Tytuł :
Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic.
Autorzy :
Neumann PJ; Peter J. Neumann () is a professor and director of the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, in Boston, Massachusetts.
Cohen JT; Joshua T. Cohen is a research associate professor at the Center for Evaluation of Value and Risk in Health, Tufts Medical Center.
Kim DD; David D. Kim is an assistant professor in the Center for Evaluation of Value and Risk in Health, Tufts Medical Center.
Ollendorf DA; Daniel A. Ollendorf is director of value measurement and global health initiatives, Center for Evaluation of Value and Risk in Health, Tufts Medical Center.
Pokaż więcej
Źródło :
Health affairs (Project Hope) [Health Aff (Millwood)] 2021 Jan; Vol. 40 (1), pp. 53-61. Date of Electronic Publication: 2020 Nov 19.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*/economics
COVID-19 Vaccines*/supply & distribution
Cost-Benefit Analysis*
Drug Costs*
COVID-19/*prevention & control
Costs and Cost Analysis/*economics
COVID-19 Testing ; Health Policy ; Humans
Czasopismo naukowe
Tytuł :
INTRODUCTION: Public Sector and Non-Profit Contributions to Drug Development - Historical Scope, Opportunities, and Challenges.
Autorzy :
Sarpatwari A
Kesselheim AS
Pokaż więcej
Źródło :
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2021; Vol. 49 (1), pp. 6-9.
Typ publikacji :
Introductory Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Costs*
Organizations, Nonprofit*
Private Sector*
Public Sector*
Drug Development/*economics
Drug Industry/*economics
Congresses as Topic ; United States
Czasopismo naukowe
Tytuł :
Comparison of Drug-Eluting Embolics versus Conventional Transarterial Chemoembolization for the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Autorzy :
Wu X; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT.
Chapiro J; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT.
Malhotra A; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT.
Kothary N; Department of Radiology, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305. Electronic address: .
Pokaż więcej
Źródło :
Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2021 Jan; Vol. 32 (1), pp. 2-12.e1. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Drug Costs*
Antibiotics, Antineoplastic/*administration & dosage
Antibiotics, Antineoplastic/*economics
Carcinoma, Hepatocellular/*drug therapy
Chemoembolization, Therapeutic/*economics
Doxorubicin/*administration & dosage
Doxorubicin/*economics
Drug Carriers/*economics
Liver Neoplasms/*drug therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibiotics, Antineoplastic/adverse effects ; Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/pathology ; Chemoembolization, Therapeutic/adverse effects ; Chemoembolization, Therapeutic/mortality ; Clinical Decision-Making ; Cost Savings ; Cost-Benefit Analysis ; Decision Support Techniques ; Decision Trees ; Disease Progression ; Doxorubicin/adverse effects ; Female ; Humans ; Liver Neoplasms/mortality ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Models, Economic ; Quality of Life ; Quality-Adjusted Life Years ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda: A descriptive time series analysis.
Autorzy :
Armstrong-Hough M; School of Global Public Health, New York University, New York, NY, United States of America.
Sharma S; Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
Kishore SP; Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Young Professionals Chronic Disease Network, New York, New York, United States of America.
Akiteng AR; Uganda Initiative for Integrated Management of Non-Communicable Diseases, Kampala, Uganda.
Schwartz JI; Uganda Initiative for Integrated Management of Non-Communicable Diseases, Kampala, Uganda.; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Dec 23; Vol. 15 (12), pp. e0241555. Date of Electronic Publication: 2020 Dec 23 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Costs*/trends
Drugs, Essential/*economics
Drugs, Essential/*supply & distribution
Noncommunicable Diseases/*drug therapy
Communicable Diseases/drug therapy ; Communicable Diseases/economics ; Health Facilities/economics ; Health Services Accessibility/economics ; Health Services Accessibility/trends ; Humans ; Noncommunicable Diseases/economics ; Private Sector/economics ; Prospective Studies ; Public Sector/economics ; Surveys and Questionnaires ; Time Factors ; Uganda
Czasopismo naukowe
Tytuł :
Drug Utilization and Drug Pricing in the Private Primary Healthcare System in Malaysia: An Employer Price Control Mechanism.
Autorzy :
Zin CS; Big Data Research Group, Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia.
Taufek NH; Big Data Research Group, Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia.
Bux SH; Big Data Research Group, Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia.
Pokaż więcej
Źródło :
Frontiers in public health [Front Public Health] 2020 Dec 07; Vol. 8, pp. 551328. Date of Electronic Publication: 2020 Dec 07 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Costs*
Drug Utilization*
Adolescent ; Adult ; Child ; Female ; Humans ; Malaysia ; Male ; Primary Health Care ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World?
Autorzy :
Kim AE; Shenandoah University Bernard J. Dunn School of Pharmacy, 1775 North Sector Ct, Winchester, VA, 22601, USA.
Choi DH; Torrid Inc., 18501 East San Jose Ave, City of Industry, CA, 91748, USA.
Chang J; University of Texas at El Paso School of Pharmacy, 500 West University Avenue, El Paso, TX, 79968, USA.
Kim SH; Shenandoah University Bernard J. Dunn School of Pharmacy, 1775 North Sector Ct, Winchester, VA, 22601, USA. .
Pokaż więcej
Źródło :
Clinical drug investigation [Clin Drug Investig] 2020 Dec; Vol. 40 (12), pp. 1107-1113. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Costs*
Reimbursement Mechanisms*
Risk Sharing, Financial*
Pharmaceutical Preparations/*economics
Germany ; Humans
Czasopismo naukowe
Tytuł :
Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study.
Autorzy :
Waterman H; School of Healthcare Sciences, Cardiff University, Cardiff, UK.
Read S; School of Healthcare Sciences, Cardiff University, Cardiff, UK .
Morgan JE; School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK.
Gillespie D; Centre for Trials Research, Cardiff University, Cardiff, South Glamorgan, UK.
Nollett C; Centre for Trials Research, Cardiff University, Cardiff, South Glamorgan, UK.
Allen D; School of Healthcare Sciences, Cardiff University, Cardiff, UK.
Weiss M; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.
Anderson P; Swansea Centre for Health Economics, Swansea University College of Human and Health Sciences, Swansea, UK.
Pokaż więcej
Źródło :
The British journal of ophthalmology [Br J Ophthalmol] 2020 Dec; Vol. 104 (12), pp. 1704-1709. Date of Electronic Publication: 2020 Mar 04.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Critical Pathways*
Drug Costs*
Medication Adherence*
Glaucoma/*drug therapy
Intraocular Pressure/*drug effects
Latanoprost/*administration & dosage
Aged ; Aged, 80 and over ; Antihypertensive Agents/administration & dosage ; Antihypertensive Agents/economics ; Female ; Follow-Up Studies ; Glaucoma/economics ; Glaucoma/physiopathology ; Humans ; Latanoprost/economics ; Male ; Middle Aged ; Ophthalmic Solutions/economics ; Prospective Studies ; Tonometry, Ocular
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies